Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia

Thrombosis Research

Volumn 132, Issue 5, 2013, Pages 511-514

  Del Principe, Maria Ilaria ^a   Buccisano, Francesco ^a   Maurillo, Luca ^a   Venditti, Daniela ^a   Cefalo, Mariagiovanna ^a   Sarlo, Chiara ^a   Di Caprio, Luigi ^a   Di Veroli, Ambra ^a   Nasso, Daniela ^a   Ceresoli, Eleonora ^a   Postorino, Massimiliano ^a   Di Piazza, Fabio ^a   Colandrea, Giulio ^a   Conti, Fabio ^a   Del Poeta, Giovanni ^a   Amadori, Sergio ^a   Venditti, Adriano ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Acute myeloid leukemia; Catheters related thrombosis; Exit site infection; Heparin prophylaxis; Sepsis; Thrombocytopenia

Indexed keywords

ENOXAPARIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOODSTREAM INFECTION; CANCER CHEMOTHERAPY; CATHETER INFECTION; CATHETER REMOVAL; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETER RELATED THROMBOSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; THROMBOCYTE COUNT;

ACUTE MYELOID LEUKEMIA; AML; CATHETERS-RELATED THROMBOSIS; CENTRAL VENOUS CATHETERS; CENTRAL VENOUS CATHETERS RELATED THROMBOSIS; CRT; CVC; DEEP VEIN THROMBOSIS; DVT; EXIT-SITE INFECTION; G-CSF; GRANULOCYTE CELL STIMULATING FACTORS; HEPARIN PROPHYLAXIS; LMWH; LOW MOLECULAR WEIGHT HEPARIN; METHYLENTETRAHYDROFOLATEREDUCTASE; MTHFR; NON-TUNNELED SUBCLAVIAN VENOUS CATHETER; PARENTERAL NUTRITION; PE; PERIPHERALLY INSERTED CENTRAL-VENOUS CATHETER; PICC; PLATELET; PLT; PN; PULMONARY EMBOLISM; SEPSIS; SVC; TF; THROMBOCYTOPENIA; TISSUE FACTOR; VENOUS THROMBOEMBOLISM; VTE; WBC; WHITE BLOOD CELL;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; UPPER EXTREMITY DEEP VEIN THROMBOSIS; YOUNG ADULT;

EID: 84886090122     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.08.007     Document Type: Article

References (39)

1. S. Siragusa, U. Armani, M. Carpenedo, A. Falanga, F. Fulfaro, and D. Imberti Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) Thromb Res 120 2012 47 55
2. A. Fennerty Venous thromboembolic disease and cancer Postgrad Med J 82 2006 642 648
3. M. Carrier, G. Le Gal, P.S. Wells, D. Fergusson, T. Ramsay, and M.A. Rodger Systemic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 5 2008 323 533
4. F.R. Rickles, and A. Falanga Molecular basis for the relationship between thrombosis and cancer Thromb Res 102 2001 215 224
5. G.C. Connolly, and A.A. Khorana Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score Thromb Res 125 2010 S1 S7
6. A. Falanga, and F.R. Rickles Management of thrombohemorrhagic Syndrome (THS) in hematologic malignancies Hematology 2007 165 171
7. M. Verso, and G. Agnelli Venous thromboembolism associated with long-term use of central venous catheters in cancer patients J Clin Oncol 21 2003 3655 3675
8. R. Willemze, S. Suciu, F. Mandelli, B. Labar, J.P. Marie, and M. Mistrik High dose (HD-AraC) vs standard dose cytosine arabinoside (SD-AraC) during induction and value of IL-2 during maintenance in acute myelogenous leukemia (AML): Impact of AraC dose on complete remission rate and toxicity (Results on the first 1700 randomized patients of the AML-12 trial of EORTC and GIMEMA Leukemia Groups) Blood 112 2008 134a
9. S. Amadori, S. Suciu, U. Jehn, R. Stasi, X. Thomas, and J.P. Marie Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomised phase 3 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto (EORTC/GIMEMA) Leukemia Groups Blood 106 2005 27 34
10. E. Estey, W. Plumkett, V. Gandhi, M. Rios, H. Kantarjian, and M.J. Keating Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia Leuk Lymphoma 9 1993 343 350
11. F. Ferrara, L. Melillo, M. Montillo, F. Leoni, A. Pinto, and G. Mele Fludarabine, cytarabine and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation Ann Hematol 78 1999 380 384
12. V. Gandhi, E. Estey, M. Keating, and W. Plunkett Fludarabine potentiates metabolism of cytarabine in patients with acute myeloid leukemia during therapy J Clin Oncol 11 1993 116 124
13. F. Lo Coco, G. Avvisati, M. Vignetti, M. Breccia, G. Gallo, and A. Rambaldi Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trials of the GIMEMA Group Blood 116 2010 3171 3179
14. T. Baglin, E. Gray, M. Greaves, B.J. Hunt, D. Keeling, and S. Machin Clinical guidelines for testing for heritable thrombophilia Br J Haematol 149 2010 209 220
15. C.A. Schiffer, K.C. Anderson, C.L. Bennett, S. Bernstein, L.S. Elting, and M. Goldsmith Platelet transfusion for patient with cancer: clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 5 2001 1519 1538
16. S. Couban, M. Goodyear, M. Burnell, P. Wasi, D. Barnes, and D. MacLeod Randomized placebo-controlled study of low- dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer J Clin Oncol 23 2005 4063 4069
17. L.A. Mermel, M. Allon, Bouza, D.E. Craven, P. Flynn, and Naomi P. O'Grady Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Disease Society of America Clin Infect Dis 49 2009 1 45
18. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, and S.M. Opal Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 Crit Care Med 11 2013 580 637
19. A. Cortelezzi, M. Moia, A. Falanga, E.M. Pogliani, G. Agnelli, and E. Bonizzoni Incidence of thrombotic complications in patientswith haematological malignancies with central venous catheters: a prospective multicentre study Br J Haematol 129 2005 811 817
20. V. De Stefano, F. Sorà, E. Rossi, P. Chiusolo, l. Laurenti, and L. Fianchi The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment Thromb Haemost 3 2005 1985 1992
21. M. Bonizzoli, S. Batacchi, G. Cianchi, G. Zagli, F. Lapi, and V. Tucci Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients Intensive Care Med 37 2011 284-28
22. M. Gunst, K. Matsushima, S. Vanek, R. Gunst, S. Shafi, and H. Frankel Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units Surg Infect (Larchmt) 12 2011 279 282
23. G.H. Ku, R.H. White, H.K. Chew, J. Harvey, H. Zhou, and T. Wun Venous thromboembolism in patients with acute leukemia: incidence, risk factors and effect on survival Blood 113 2009 3911 3917
24. F. Elice, and F. Rodeghiero Hematologic malignancies and thrombosis Thromb Res 129 2012 360 366
25. C.T. Esmon The interactions between inflammation and coagulation Br J Haematol 131 2005 417 430
26. M. Levi, T. van der Poll, and H.R. Buller Bidirectional relation between inflammation and coagulation Circulation 109 2004 2698 2704
27. R. Castelli, B. Ferrari, A. Cortelezzi, and A. Guariglia Thromboembolic complications in malignant haematological disorders Curr Vasc Pharmacol 8 Jul. 2010 482 494
28. D. Xiang, E. Verbeken, A.T.L. Van Lommel, M. Stas, and I. De Wever Composition and formation of the sleeve enveloping a central venous catheter J Vasc Surg 28 1998 260 271
29. D.Z. Xiang, E.K. Verbeken, A.T.L. Van Lommel, M. Stas, and I. De Wever Sleeve-related thrombosis a new form of Catheter-Related thrombosis Thromb Res 104 2001 7 14
30. P. Debourdeau, D. Kassab Chahmi, G. Le Gal, I. Kriegel, E. Desruennes, and M.C. Douard 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: Report from the working group Ann Oncol 20 2009 1459 1471
31. N. Levitan, A. Dowlati, H.I. Remick SC Tahsildar, S.C. Tahsildar, L.D. Sivinski, and R. Beyth Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 1999 285 291
32. P.D. Stein, A. Beemath, F.A. Meyers, E. Skaf, J. Sanchez, and R.E. Olson Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 2006 60 68
33. M.M. Samama, A.T. Cohen, J.Y. Damon, L. Desjardins, A. Eldor, and C. Janbon A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients N Engl J Med 341 1999 793 800
34. A. Leizorovicz, A.T. Cohen, A.G. Turpie, C.G. Olsson, P.T. Vaitkus, and S.Z. Goldhaber Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 2004 874 879
35. C.A. Schiffer, P.B. Mangu, J.C. Wade, D. Camp-Sorrell, D.G. Cope, and B.F. El-Rayes Central venous catheter care for the patient with cancer: american society of clinical oncology clinical practice guideline J Clin Oncol 31 2013 1357 1370
36. C.J. Van Rooden, E.F. Schippers, R.M. Barge, F.R. Rosendaal, H.F. Guiot, and F.J. van der Meer Infectious complications of central venous catheters increase the risk of catheter related thrombosis in hematology patients: a prospective study J Clin Oncol 23 2005 2655 2660
37. A. Abdelkefi, L. Torjman, S. Labed, T.B. Othman, W. Achour, and A. Lakhal Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease J Clin Oncol 23 2005 7864 7870
38. P.W. Kamphuisen, and A.Y.Y. Lee Catheter-related thrombosis: lifeline or a pain in the neck? Hematology Am Soc Hematol Educ Program 2012 2012 638 644
39. D. Imberti, D. Vallisa, E. Anselmi, C.F. Moroni, R. Bertè, and A. Lazzaro Safety and efficacy of enoxaparin in venous thromboembolic disease during acute leukemia Tumori 90 2004 390 393